Cornercap Investment Counsel Inc Passage Bio, Inc. Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.82 - $1.19 $42,411 - $61,547
-51,721 Reduced 50.96%
49,767 $46,000
Q1 2023

May 11, 2023
BUY
$0.96 - $1.88 $1,186 - $2,323
1,236 Added 1.23%
101,488 $97,000
Q3 2022

Nov 14, 2022
BUY
$1.22 - $2.48 $40,447 - $82,221
33,154 Added 49.41%
100,252 $125,000
Q2 2022

Aug 15, 2022
BUY
$1.63 - $3.46 $109,369 - $232,159
67,098 New
67,098 $158,000

Others Institutions Holding PASG

# of Institutions
47
Shares Held
38.7M
Call Options Held
7.7K
Put Options Held
0
View Full List

About Passage BIO, Inc.

PASG Quotes by TradingView
  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $32.1M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email